edetic acid has been researched along with deferiprone in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hershko, C; Konijn, AM; Link, G | 1 |
| Andrews, GK; Bittel, D; Hider, RC | 1 |
| Cook, J | 1 |
| Clarke, JJ; Dunkel, VC; San, RH; Seifried, HE; Whittaker, P | 1 |
| Devanur, LD; Hider, RC; Neubert, H | 1 |
| Kummel, AC; Liberman, A; Pohaku Mitchell, KK; Trogler, WC | 1 |
| Kontoghiorghes, GJ | 1 |
| Aburjai, TA; Alkhalil, SM; Ikeda, R; Komatsu, H; Kuroda, N; Nakashima, K; Wada, M | 1 |
| Barton, LL; Granat, AS; Hider, R; Kherbik, N; Khurshid, AN; Lin, HC; Lyle, DA; Ritz, NL | 1 |
| Crumbliss, AL; Harrington, JM; Mysore, MM | 1 |
1 review(s) available for edetic acid and deferiprone
| Article | Year |
|---|---|
Iron chelators for thalassaemia.
Topics: Administration, Oral; Aza Compounds; Chelating Agents; Deferiprone; Deferoxamine; Edetic Acid; Humans; Iron; Iron Chelating Agents; Iron Overload; Long-Term Care; Pyridones; Thalassemia | 1998 |
9 other study(ies) available for edetic acid and deferiprone
| Article | Year |
|---|---|
Competition between iron(III)-selective chelators and zinc-finger domains for zinc(II).
Topics: Animals; Binding, Competitive; Deferiprone; DNA-Binding Proteins; Edetic Acid; Iron; Iron Chelating Agents; Mice; Pyridones; Recombinant Proteins; Transcription Factor MTF-1; Transcription Factors; Zinc; Zinc Fingers | 1999 |
Radiation sensitization of mammalian cells by metal chelators.
Topics: Animals; Cell Cycle; Chelating Agents; Colony-Forming Units Assay; Cricetinae; Cricetulus; Deferiprone; Deferoxamine; DNA Replication; Edetic Acid; Fibroblasts; Genes, p53; Humans; Iron Chelating Agents; Lung; Lung Neoplasms; Mimosine; Pyridones; Radiation-Sensitizing Agents; S Phase; Tumor Cells, Cultured | 2001 |
Genotoxicity of iron chelators in L5178Y mouse lymphoma cells.
Topics: Animals; Deferiprone; Edetic Acid; Iron Chelating Agents; Lymphoma; Mice; Mutagenicity Tests; Phenanthrolines; Pyridones; Razoxane; Tumor Cells, Cultured | 2001 |
The fenton activity of iron(III) in the presence of deferiprone.
Topics: Ascorbic Acid; Deferiprone; Edetic Acid; Hydrogen Peroxide; Hydroxyl Radical; Iron; Iron Chelating Agents; Oxidation-Reduction; Pyridones; Spectrometry, Mass, Electrospray Ionization | 2008 |
Iron(III)-doped, silica nanoshells: a biodegradable form of silica.
Topics: Animals; Biocompatible Materials; Cattle; Deferiprone; Deferoxamine; Edetic Acid; Ferric Compounds; Humans; Iron Chelating Agents; Nanoshells; Pyridones; Serum; Silicon Dioxide; Transferrin | 2012 |
The proceedings of the 20th International Conference on Chelation held in the USA: advances on new and old chelation therapies.
Topics: Chelating Agents; Chelation Therapy; Deferiprone; Deferoxamine; Edetic Acid; Humans; Iron Overload; Metals; Poisoning; Pyridones; Risk Assessment; Thalassemia; Treatment Outcome; United States | 2013 |
In vitro screening of Fe2+-chelating effect by a Fenton's reaction-luminol chemiluminescence system.
Topics: Deferiprone; Deferoxamine; Edetic Acid; Ferrous Compounds; Iron Chelating Agents; Luminescence; Luminol; Molecular Structure; Phenanthrolines; Pyridones | 2014 |
Bismuth(III) deferiprone effectively inhibits growth of Desulfovibrio desulfuricans ATCC 27774.
Topics: Anti-Bacterial Agents; Bismuth; Coordination Complexes; Deferiprone; Desulfovibrio; Edetic Acid; Iron Chelating Agents; Microbial Sensitivity Tests; Pyridones | 2016 |
The kinetics of dimethylhydroxypyridinone interactions with iron(iii) and the catalysis of iron(iii) ligand exchange reactions: implications for bacterial iron transport and combination chelation therapies.
Topics: Bacteria; Catalysis; Chelation Therapy; Deferiprone; Deferoxamine; Edetic Acid; Ferric Compounds; Humans; Hydroxamic Acids; Ion Transport; Iron; Iron Chelating Agents; Iron Overload; Kinetics; Ligands; Pyridones | 2018 |